Retatrutide used for the treatment of type 2 diabetes and obesity. Retatrutide is a triple-peptide therapy with GLP-1, GIP, and Glucagon receptor (GCGR) agonist effects; The addition of glucagon receptor agonism affects the pancreatic cells to reduce insulin release.
Original price was: $100.00.$70.00Current price is: $70.00.
Peptides will arrive in a lyophilized (powder) form for maximum stability
9 in stock
Original price was: $100.00.$70.00Current price is: $70.00.
Original price was: $100.00.$70.00Current price is: $70.00.
9 in stock